In addition, utilizing the FBN-ARO-KO and GFAP-ARO-KO mice in disorders other than global cerebral ischemia could also help to further delineate the role of ADE2 and NDE2 in various aspects of these other neurological disorders. This evidence concerns the gene FBN1 and nervous system disorder.